Healthed AustraliaHealthed Australia

Cardiovascular risk assessment in lipid management

View descriptionShare

In this Healthed lecture, Dr Robert Hungerford discusses the latest evidence-based recommendation to lower LDL-C targets even further in various at-risk groups, as well as the most effective means of reaching those targets in real-world Australian clinical practice. He will also present the value of combination therapy, the value of starting combination early, the role of the newer PCSK9 inhibitors and their current PBS eligibility criteria.

Healthed Australia

Healthed's medical education channel features the latest high quality clinical interviews and lectur 
Social links
Recent clips
Browse 191 clip(s)